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ABSTRACT
The biochemical and histological changes following 60 days administration of daily doses
equivalent to 1/20 LDo of lithium lactate and hydrochlorothiazide, as such and in
association, were studied in male Wistar rats. No mortality or overt signs of toxicity were
observed during the experiment and the serum activities of transaminases, alkaline
phosphatase and cholinesterase were not significantly modified compared to controls. The
histopathological examination of all the investigated organs: kidney, liver, brain and spleen,
revealed significant lesions which were time-dependant and more pronounced in the
association group. Although the changes were mostly inflammatory and congestive, it was
proved that the concomitant administration of lithium and hydrochlorothiazide is potentially
dangerous, increasing lithium’s nephrotoxicity and the thiazide diuretic’s hepatotoxicity.
INTRODUCTION
Lithium is a major drug in psychiatry, being used in the treatment and prophylaxis of bipolar
affective disorder, but also in antidepressant-resistant patients (1,2,3). Lithium’s
pharmacokinetics is relatively simple, but the ion can pharmacokinetically interact with
many usual drugs which may be prescribed for the treatment of an illness accompanying the
psychiatric disorder: diuretics, nonsteroidal anti-inflammatory drugs, antibiotics,
bronchodilators (4,5,6,7). The therapeutic index of the ion being low, such interactions may
result either in inefficient levels or in toxic phenomena.
The thiazide diuretics have been recommended by some authors for the treatment of
lithium-induced nephrogenic diabetes insipidus and in severe manic-depressive illness in
which high doses of lithium do not produce therapeutic serum concentrations (8). The
treatment can be efficient but also dangerous, due to a decrease in lithium’s renal
clearance.
Thiazide diuretics inhibit sodium reabsorption in the distal tubule, inducing sodium
depletion. During long-term administration, the diuretic-induced sodium depletion results in
a compensatory increased reabsorption of both sodium and lithium in the proximal tubule.
Approximately 80% of lithium that has been glomerulary filtered is usually reabsorbed, but
sodium depletion induces about 86% reabsorption (9). Therefore lithium concentrations can
be significantly increased by diuretic therapy, with risk of intoxication.
In order to evaluate this risk, we have studied in male Wistar rats the biochemical and
histological changes during long-term administration of lithium and hydrochlorothiazide as
such and associated.
MATERIALS AND METHODS
Animals. In the experiment were included 3 experimental groups and a negative control
group, all four consisting of 30 male Wistar rats (body weight 122 +__ 15 g). The animals were
maintained in standard food and microclimate conditions during the whole period of
observation.
Dosing. The substances were administered for 60 days, orally by intubation, lithium as
lactate salt dissolved in distilled water and hydrochlorothiazide in aqueous suspension
prepared with Tween 80.
The dosages were the following:
experimental group I: a daily dose of lithium lactate equivalent to 1/20 LDo (105 mg/kg)
-experimental group I1: a daily dose of hydrochlorothiazide equivalent to 1/20 LDo (309
mg/kg)
-experimental group II1: a daily dose of 1/20 LDoof lithium lactate associated with 1/20
LDo of hydrochlorothiazide.
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Negative controls received the same amount of Tween 80 in distilled water.
Experimental Design. Animals were checked daily for clinical signs and mortalities and
weighed individually each week. On days 20, 40 and 60 of the experiment 10 rats from each
group were sacrificed by decapitation, blood and the main organs: kidneys, liver, brain,
spleen, heart and lungs being collected. The organs were weighted and their relative
weights were determined. Serum was separated for lithium quantification by atomic
absorption and for enzyme assay.
The serum activities of: transaminases (GOT, GTP), alkaline phosphatase (AP)and
cholinesterase (ChE) were assayed. Analytical determination of transaminase activity was
performed using a colorimetric method that measures for GOT activity the conversion of
aspartic acid and o-ketoglutaric acid to glutamic acid and oxaloacetic acid, and for GPT
activity the conversion of alanine and (-ketoglutaric acid to glutamic acid and pyruvic acid.
The reaction product (oxaloacetic or pyruvic acid) reacts with dinitrophenylhydrazine to
form a coloured hydrazone that can be determined by its absorbance in the visible range
(505 nm)(10). Alkaline phosphatase was assayed using p-nitrophenylphosphate as substratum.
The p-nitrophenol formed has an absorption maximum in alkaline medium at 405 nm (11).
Serum cholinesterase was determined using as substratum butirylthiocholine. Thiocholine
resulted in the presence of the enzyme reacts with 5,5’-dithiobis-2-nitrobenzoic acid to form
a yellow product with an absorption maximum at 412nm (11).
Organ fragments of kidney, liver, brain and spleen were prepared according to the classical
technique (10% formaldehyde fixation, paraffin embedded) and stained with haematoxylin-
eosin for the microscopic examination, which was performed blindly.
Statistical analysis. The results are presented as mean values + standard deviation and
experimental groups were compared with negative controls by Anova analysis of variance
and post-tests.
RESULTS
No compound-related mortality or overt signs of toxicity were observed during the
experiment.
Serum Drug Analysis
Serum lithium concentrations during the experiment for lithium-treated groups were between
0.245 and 0.428 mmol/I after 20 days of administration, between 0.304 and 0.385 mmol/I
after 40 days, and between 0.312 and 0.402 mmol/I after 60 days.
Clinical chemistry
The evaluation of the enzymatic activities of transaminases and alkaline phosphatase
revealed no significant variations from controls (Figures 1-3). Cholinesterase serum values
are significantly decreased (p< 0.05) following 60 days of administration in the association
group (Figure 4).
Anatomic Pathology
Organ weights. There were no compound-related organ weights findings. Slight variations
between individual animals in both absolute and relative organ weights, which sometimes
achieved statistical significance were observed, but were considered incidental and
unrelated to the treatment.
Necropsy findings. No macroscopic changes of the organs were observed.
Histopathology.
Kidney. After 2o days of lithium administration the changes consisted mostly in tubular
dystrophy and a slight glomerular hypertrophy. After 40 days the tubular dystrophy, especially
at proximal level, is more pronounced and a serous and fibrino-haemoragic glomerulitis can
also be seen. The changes evolve in time, both at tubular and glomerular level and after 60
days the presence of a compact eosinophilic mass in the tubules can be observed, probably
future hyaline bodies.
The administration of hydrochlorothiazide induced in 20 days a pronounced intra- and
periglomerular blood stasis. The space between the visceral and parietal layer of Bowman’s
capsule is enlarged and tubular epithelial cells are modified. Cells showed irregular shape
and surface alterations with extrusions reaching into the lumen. After 40 days the changes
are more pronounced and early signs of serous glomerulitis are observed. At the end of the
experiment, in the enlarged space of Bowman’s capsule an eosinophilic mass is present.
Tubular dystrophic changes are accompanied by incipient hyaline bodies formation.
The changes induced by the association of the two substances are earlier and more
pronounced.
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Blood stasis is very pronounced from the beginning of the experiment. Both alterations of
glomerular capillaries and the space of Bowman’s capsule are of special interest. At day 40
of the experiment fibrino-haemoragic glomerulitis, glomerular hypertrophy and pronounced
tubular dystrophy are observed. At the end of the experiment the interstitial, periglomerular
and peritubular stasis are evident, the glomerular hypertrophy and the tubular dystrophy are
very pronounced.
Liver. After 20 days of lithium administration, the sinusoid capillary dilatation and the
presence of o diffuse lymphoplasmocytic infiltrate are seen. These become more evident in
time, the structural disorganisation of the Remak cell columns and the presence of a nodule-
like lymphoid infiltrate in the portal space being observed after 60 days.
Hydrochlorothiazide-induced hepatic changes are more pronounced and they become
evident earlier. After 20 days, the structural disorganisation of Remak cell columns and even
blood stasis in the portal space are observed. In time, an increase in binuclear hepatocyte
number occurs and lymphoid nodules are present in the portal space. At the end of the
experiment, the structural disorganisation and the enlargement of sinusoid capillaries are
evident, the number of hepatocytes with cytoplasmic vacuolation is increased and a blood
stasis is also present.
In the association group, the changes are similar but even earlier and much more
pronounced. After 60 days the structural disorganisation associated with blood stasis,
enlargement of sinusoid capillaries, increased number of binuclear hepatocytes and
inflammatory nodules in the portal space are observed.
Brain. After 20 days of lithium administration, congestion and haemorrhage at meningeal
level and a slight interstitial oedema. After 40 days, the interstitial oedema is more
pronounced, a hyperplasia of the neurones and of the choroid plexus is .observed. At the end
of the experiment, the hyperplasia of the choroid plexus and the blood stasis are evident.
In hydrochlorothiazide group the changes are more pronounced, the hyperplasia of the
choroid plexus is observed even after 20 days of administration and blood stasis and
haemorrhage are already evident. After 40 days, the hyperplasia of the choroid plexus is
more important and after 60 days a very pronounced interstitial oedema is present.
Figure ,q. Brain, association group, 60 days, col.H.E.
Blood stasis and pronounced interstitial oedema
The association of lithium with hydrochlorothiazide potentiates the histological changes.
The hyperplasia of the choroid plexus occurs earlier, as well as the interstitial oedema and
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after 60 days of administration the oedema is very pronounced and haemorrhage can also
be observed (Figure 5).
Spleen. No significant changes were seen in lithium group at the beginning of the
administration. But in time the white pulp becomes slightly hypertrophied and the red pulp
has very few erythrocytes in the interstitium. After 60 days, the white pulp is hypertrophied
and the red pulp is rich in lymphocytes and especially in macrophages.
In hydrochlorothiazide group, splenic changes can be observed even after 20 days of
administration. The white pulp is hypertrophied and the periarteriolar lymphatic sheaths are
thickened. The cords of Billroth in the red pulp are also hypertrophied and at the end of the
experiment very few red blood cells and macrophages are present in the network.
The association induces progressive and more dramatic splenic changes. After 20 days the
white pulp is slightly hypertrophied and the red pulp is rich in cells, with many red blood
cells in the network. After 40 days the periarteriolar lymphatic sheaths begin to thicken. The
changes are obvious after 60 days when in the white pulp thick periarteriolar lymphatic
sheaths and in the red pulp thick cords, of Billroth are observed. The red pulp is also very rich
in red blood cells and macrophages.
DISCUSSION
The results of the experiment pointed out that the long-term administration of lithium in rats
results in toxic effects, although no mortality was observed.
Lithium serum concentration during the experiment did not attain levels between 0.6 and
1.2 mmol/ which are considered toxic (12).
In these conditions, the activities of transaminases, alkaline phosphatase or cholinesterase,
which are indicators of cytolysis, cholestasis or of the proteosynthetic function of the liver are
not significantly modified. These results were confirmed by the histopathological
examination which revealed only inflammatory, congestive or degenerative lesions. In the
association group, where a hepatic structural disorganisation is observed, the activity of
serum cholinesterase is decreased after 60 days.
Studies on patients following long-term administration did not confirm the hepatotoxic effect
of lithium (13). Anyway, animal experiments revealed degenerative, dystrophic and
congestive changes (14,15). As the concomitant administration of lithium and of drugs
affecting the liver, like thiazide diuretics, results in an increased incidence of hepatic
changes, a lithium hepatotoxic effect in these particular conditions should probably be
taken into account.
The kidney is a major target organ for lithium’s toxicity, and therefore highly investigated.
Long-term animal studies revealed interstitial fibrosis, tubular atrophy and glomerular
sclerosis (16,17). The renal changes observed during the present experiment were at the
glomerular, interstitial and especially tubular level. The glomerular lesions can be both
primary as well as secondary, due to tubular and interstitial changes. The severe tubular
dystrophy is accompanied by sclerosis and it can be explained by the direct nephrotoxic
effect of lithium. The changes are time-dependent and are more frequent at the association
with hydrochlorothiazide, which in its turn can induce renal lesions. The thiazide diuretic,
due to an increased tubular reabsorption, can increase lithium’s concentration at kidney
level (9). The elevated concentration may induce renal lesions, diminishing even more the
elimination of the ion.
At the CNS level, congestion, haemorrhage and hyperplasia of the choroid plexus and of the
neurones are the most striking phenomena. The changes have an increased incidence in
the association group, not only due to an intrinsic toxic effect of the diuretic, but also to a
15% increase in lithium’s brain concentrations as supported by previous research (18).
The splenic lesions are less important in lithium group, where they become evident only at
the end of the experiment. The association with hydrochlorothiazide induces radical
changes, with hypertrophy of both white and red pulp and an increase in the number of cells
in the network: lymphocytes, macrophages and red blood cells.
CONCLUSIONS
The long-term administration of lithium, as such and associated with the thiazide diuretic
hydrochlorothiazide, induces toxic effects correlated to the period of administration. Even
though no important behavioural or biochemical changes were observed, the renal, hepatic,
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cerebral and splenic lesions are significant. Although the kidney and in a greater extent the
liver, have a certain regeneration capacity, and even in this case when the changes are
mostly inflammatory, congestive and degenerative, the fact that they are more frequent in
the association group raises the question of their irreversibility.
On the basis of these results, we can presume that the concomitant administration of lithium
and hydrochlorothiazide increases lithium’s nephrotoxic effect and the thiazide diuretic’s
hepatotoxicity.
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